Skip to main content

EN
ÍS

Forsíða

Forsíða

Berglind Ósk Einarsdóttir - Dósent

Berglind Ósk Einarsdóttir

–

Heilbrigðisvísindasvið

Berglind Ósk Einarsdóttir

Dósent

Aðsetur
Sturlugata 8
Tölvupóstur
boe [hjá] hi.is

Starfseining
Læknadeild, Geisla- og lífeindafræði

ORCID vefsíða
https://orcid.org/0000-0002-5227-8149
Rannsóknagátt – Berglind Ósk Einarsdóttir

Útgefið efni

2024

Long-term use of rituximab increases T cell count in MS patientsFrontiers in Immunology

2021

Mitf reprograms the extracellular matrix and focal adhesion in melanomaeLife
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanismsAmerican Journal of Human Genetics

2020

CorrectionCell Death and Disease
Molecular profiling of driver events in metastatic uveal melanomaNature Communications

2018

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaCell Death and Disease
Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primaryJCO Precision Oncology

2017

BRAF^V600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cellsProceedings of the National Academy of Sciences of the United States of America
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma in melanomaCell death & disease

2016

Validation and development of MTH1 inhibitors for treatment of cancerAnnals of Oncology
Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenograftsOncotarget

2014

Hip fractures and bone mineral density in the elderly - Importance of serum 25-hydroxyvitamin DPLoS ONE
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP poolNature
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisionsOncotarget

2013

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancerCancer Medicine

Sérsvið:

Frumulíffræði

Sameindalíffræði

Utanfrumuerfðaefni